EDIGENE is a biotechnology company focused on leveraging cutting-edge genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of genetic diseases and cancer. The company has established its proprietary ex vivo genome-editing platforms for hematopoietic stem cells and T cells, an in vivo therapeutic platform based on RNA base editing, and high-throughput genome-editing screening to discover novel targeted therapies.
Igniting Greatness in Companies and Their People
Best and Brightest strives to recognize the most influential, trend-setting companies across the country and regionally in focused programs.
Contact Us
The National Association for Business Resources does not in any way endorse winning companies businesses, brands, products or services, and has the right to prohibit companies from participating in the selection process of a Best and Brightest program based on specific industries, as well as any ethical concerns that may arise.